Press release
Global Valvular Heart Disease Treatment Market Analysis 2019 by Technological Progress, Regional Outlook And Forecast to 2025
As per the report published by Fior Markets, The global valvular heart disease treatment market is expected to grow from USD XX.XX Million in 2017 to USD XX.XX Million by 2025, at a CAGR of X.XX% during the forecast period from 2018-2025. The North America region emerged as the leader in the global valvular heart disease treatment market with a 44.91% share of revenue in 2017.
"Valvular Heart Disease Treatment Market by Disease (Aortic Valve,Mitral Valve, Others), Diagnosis, Treatment, End User, Regions",and Global Forecast 2018-2025.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/386027/request-sample
Major players in the global valvular heart disease treatmentmarket are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, PLC, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., Micro Interventional Devices, Inc., Symetis SA, Jenavalve Technology, Inc., TTK Healthcare Limited, Colibri Heart Valve, LLC, Lepu Medical Technology Co., Ltd., Braile Biom ica, and among others. Newborns and infants, with congenital valve defects who may be too small to use currently-marketed heart valves. Thus to fulfil this unmet demand US FDA has approved the Masters Series Mechanical Heart Valve. These new heart valves are small enough to be used in newborn pediatric patients to treat heart defects.
Disease segment is divided into aortic valve disorder, mitral valve disorder, pulmonary valve disorder and others. Due to growing prevalence of aortic stenosis and aortic valve regurgitation disorders the aortic valve disorder segment emerged as the leading segment with a 41.37% share of market revenue in 2017. Mitral valve Mitral valve segment also accounted for a significant share of the global valvular heart disease treatment market in 2017.Diagnosis segment is categorized into cardiac catheterization, electrocardiogram (ECG), chest x-ray, stress testing and others. Due to property of electrocardiogram (ECG) for being easy to use and cost effective, the electrocardiogram (ECG) segment emerged as the largest diagnosis segment with a 34.53% share of market revenue 2017. Cardiac catheterization segment is anticipated to grow at an accelerated CAGR of X.XX% over the forecast period. Treatment segment is fragmented into medication and surgery. Surgery is further divided into valve repair and valve replacement. The valvular heart diseases can be treated by medication such as Antithrombotic (clot-preventing) medications such as aspirin or ticlopidine. Surgery are performed using endovascular techniques which are minimally invasive and with help of transcatheter valves, and other devices and mechanical circulatory support.End user is segmented into hospital & clinics, ambulatory surgical centers and research institutes. The hospitals & clinics segment led the global valvular heart disease treatment market with a 56.52% share of market revenue in 2017. Whereas the research institutes segment is projected to grow at the fastest pace over the forecast period.
BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/valvular-heart-disease-treatment-market-by-disease-aortic-386027.html
Even though the factors such as rising geriatric population, increase in prevalence of heart valve disease are driving the global valvular heart disease treatment market, the high cost of treatment as well as shortage of skilled surgeons are expected to hold back the market growth.
Customization of the Report:This report can be customized to meet the client's requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.
Contact Us
Mark Stone
Sales Manager
Office-102, Sanskriti Aspirations
Baner Road, Pune,
MH 411045
India
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com
About Us:
Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients' objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. We sell market research reports obtained from major publishers from various industries, in which a comprehensive overview of the market is provided along with statistical forecasts, strategic recommendations, detailed segmentation, current market scenario, competitive landscape and key trends.
"Valvular Heart Disease Treatment Market by Disease (Aortic Valve,Mitral Valve, Others), Diagnosis, Treatment, End User, Regions",and Global Forecast 2018-2025.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/386027/request-sample
Major players in the global valvular heart disease treatmentmarket are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, PLC, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., Micro Interventional Devices, Inc., Symetis SA, Jenavalve Technology, Inc., TTK Healthcare Limited, Colibri Heart Valve, LLC, Lepu Medical Technology Co., Ltd., Braile Biom ica, and among others. Newborns and infants, with congenital valve defects who may be too small to use currently-marketed heart valves. Thus to fulfil this unmet demand US FDA has approved the Masters Series Mechanical Heart Valve. These new heart valves are small enough to be used in newborn pediatric patients to treat heart defects.
Disease segment is divided into aortic valve disorder, mitral valve disorder, pulmonary valve disorder and others. Due to growing prevalence of aortic stenosis and aortic valve regurgitation disorders the aortic valve disorder segment emerged as the leading segment with a 41.37% share of market revenue in 2017. Mitral valve Mitral valve segment also accounted for a significant share of the global valvular heart disease treatment market in 2017.Diagnosis segment is categorized into cardiac catheterization, electrocardiogram (ECG), chest x-ray, stress testing and others. Due to property of electrocardiogram (ECG) for being easy to use and cost effective, the electrocardiogram (ECG) segment emerged as the largest diagnosis segment with a 34.53% share of market revenue 2017. Cardiac catheterization segment is anticipated to grow at an accelerated CAGR of X.XX% over the forecast period. Treatment segment is fragmented into medication and surgery. Surgery is further divided into valve repair and valve replacement. The valvular heart diseases can be treated by medication such as Antithrombotic (clot-preventing) medications such as aspirin or ticlopidine. Surgery are performed using endovascular techniques which are minimally invasive and with help of transcatheter valves, and other devices and mechanical circulatory support.End user is segmented into hospital & clinics, ambulatory surgical centers and research institutes. The hospitals & clinics segment led the global valvular heart disease treatment market with a 56.52% share of market revenue in 2017. Whereas the research institutes segment is projected to grow at the fastest pace over the forecast period.
BROWSE COMPLETE REPORT AND TABLE OF CONTENTS:https://www.fiormarkets.com/report/valvular-heart-disease-treatment-market-by-disease-aortic-386027.html
Even though the factors such as rising geriatric population, increase in prevalence of heart valve disease are driving the global valvular heart disease treatment market, the high cost of treatment as well as shortage of skilled surgeons are expected to hold back the market growth.
Customization of the Report:This report can be customized to meet the client's requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.
Contact Us
Mark Stone
Sales Manager
Office-102, Sanskriti Aspirations
Baner Road, Pune,
MH 411045
India
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com
About Us:
Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients' objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. We sell market research reports obtained from major publishers from various industries, in which a comprehensive overview of the market is provided along with statistical forecasts, strategic recommendations, detailed segmentation, current market scenario, competitive landscape and key trends.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
